Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:18 AM
Ignite Modification Date:
2025-12-25 @ 3:18 AM
NCT ID:
NCT04556305
Eligibility Criteria:
Inclusion Criteria:
* self-identified as women
* ≥ 65 years old
* read/speak English
* patient in the Rush Heart Center for Women
* history of CVD (e.g., coronary artery disease, hypertension) and receiving guideline-directed medical therapy when appropriate
* no regular moderate-vigorous physical activity (≥ 30 minutes ≥ 3 days per week in the past month)
* no cognitive training program in the past month
* no disabilities preventing regular physical activity (Physical Activity Readiness Questionnaire, which includes cardiac and lung disease symptoms)
* written approval from cardiology provider (Physical Activity Readiness Medical Examination); no self-reported significant hearing loss that interferes with normal conversation
* access to a Bluetooth-capable phone or tablet
Exclusion Criteria:
* symptoms of unstable cardiac or pulmonary disease in the past month (Physical Activity Readiness Questionnaire)
* blood pressure (systolic ≥ 160 or diastolic ≥ 100 mm Hg)
* cognitive status score \< 19 on the blind version (for phone administration) of the Montreal Cognitive Assessment (MoCA) consistent with significant cognitive impairment
* diagnosis of a neurological disease found in the electronic health record (e.g., Alzheimer's disease dementia, Parkinson's disease, vascular dementia)
* transient ischemic attack or small-vessel stroke in the past three months
* taking anti-psychotic medication
* diabetes with an A1C ≥ 9.0 within the past six months
* end-stage renal disease on dialysis (Stage 5)
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
65 Years
Study:
NCT04556305
Study Brief:
Protocol Section:
NCT04556305